|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1997-8-25
|
|
pubmed:abstractText |
The aim of this study was to assess the antiarrhythmic efficacy and safety of d,l-sotalol in patients with ventricular tachycardia (VT) or ventricular fibrillation (VF) and in survivors of cardiac arrest and to identify the factors that are associated with arrhythmia suppression and therefore might be helpful in predicting drug efficacy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
487-95
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9247523-Administration, Oral,
pubmed-meshheading:9247523-Anti-Arrhythmia Agents,
pubmed-meshheading:9247523-Electric Stimulation,
pubmed-meshheading:9247523-Female,
pubmed-meshheading:9247523-Follow-Up Studies,
pubmed-meshheading:9247523-Heart Arrest,
pubmed-meshheading:9247523-Humans,
pubmed-meshheading:9247523-Male,
pubmed-meshheading:9247523-Middle Aged,
pubmed-meshheading:9247523-Sotalol,
pubmed-meshheading:9247523-Tachycardia, Ventricular,
pubmed-meshheading:9247523-Torsades de Pointes,
pubmed-meshheading:9247523-Ventricular Fibrillation
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest.
|
|
pubmed:affiliation |
Hospital of the Westfälische Wilhelms-University, Department of Cardiology and Angiology, Münster, Germany. w.haverkamp@uni-muenster.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
